Sign up for Enews

Enter your e-mail address to receive our free monthly e-newsletter.

Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis

Ascendant Dx

Ascendant Dx is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.

Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.

We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods. 


  • Life Sciences
  • Biotechnology

Contact Information

Management Team

  • Omid Moghadam,
  • Chief Executive Officer
  • Anna Daily, PhD
  • Senior Scientist
  • Kimberley Fuller,
  • Director of Market Research
  • and Business Development

Latest News